Significantly lower rates of symptom rebound and rebound severity seen four weeks after eradication for those with infection.

Be sure to discuss the risks and benefits of prolonged PPI therapy with your healthcare provider for optimal safety. H2 ...

Currently, coxib therapy is more expensive than combination therapy using a nonselective NSAID plus a PPI. Conclusions: Compared with combination therapy including a nonselective NSAID and PPI ...

A previous guideline was published in 2017. It had maintained the recommendation of a proton pump inhibitor-clarithromycin ...

The authors conclude that gastric acid suppression induced by PPIs, but not by H 2 RAs, is associated with an increased risk of salmonella and campylobacter enteric infections. They suggest that ...

If long-term PPI therapy is to be used, monitoring of bone density may be considered in selected patients, especially in postmenopausal women.

Use the lowest dose of Protonix and for the shortest duration of PPI therapy appropriate to the condition. PPI therapy may be associated with a greater risk of osteoporosis-related fractures of ...

The authors performed two analyses—a cross-sectional study and a longitudinal study—to investigate the relationship between PPI therapy and osteoporosis and the effects of PPIs on BMD.

PPIs lower gastrointestinal bleeding risk in AMI patients on DAPT, with no added cardiovascular risk. Key findings here.

Although proton pump inhibitors are widely prescribed for gastrointestinal (GI) diseases, numerous studies have raised concerns about their potential adverse effects on kidney hea ...

Detailed price information for Inozyme Pharma Inc (INZY-Q) from The Globe and Mail including charting and trades.

Patients who were positive for H pylori were randomly assigned to receive bacterial eradication with triple therapy for 2 weeks before or after 4 weeks of PPI therapy. “The present study ...